About this trial
The goal of this clinical trial is to learn if a conditional social transfer works to improve rates of complementary breastfeeding. It will also learn about the impacts of social transfers on maternal and child health and development. The main questions it aims to answer are:
* Does the social transfer increase complementary breastfeeding rates at 24-months postpartum? * Does the social transfer increase complementary breastfeeding duration? * Does the social transfer impact child health and development? * Does the social transfer impact maternal physical and mental health?
Researchers will compare a conditional social transfer to a control group that only receives education about breastfeeding recommendations to see if a conditional social transfers works to increase complementary breastfeeding.
Participants will:
Receive a pamphlet explaining the current recommendations of breastfeeding Receive instructions that if they meet the recommendation to breastfeed until 24-months postpartum they receive a social transfer or receive no additional information Complete home visits at 12- and 24-months postpartum Complete detailed questionnaire
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Are enrolled in the Taabo multigenerational birth cohort (MGC)
Completed the postpartum interview of the Taabo MGC
Have a child who is within two weeks of their 12-month birthday,
are breastfeeding at time of recruitment,
Disqualifiers
Plans to move permanently outside study area
Has a medical, intellectual or psychological disability
Contraindication for breastfeeding
Children born with < 2500 grams
Trial design
Parallel
Treatments tested in this trial
Social Transfer
Other interventionA social transfer will be given conditioned upon breastfeeding at 24-months postpartum.
Treatment groups
Trial outcomes
Primary outcomes
Prevalence of Complementary Breastfeeding
Prevalence of complementary breastfeeding at 24 months postpartum.
Complementary Breastfeeding Duration
Duration of complementary breastfeeding in weeks.
Secondary outcomes
Weight-for-Age z-score
Infants will be weighed in kilograms by a mobile weighing scale. Measurements will be analyzed as age standardized z-scores.
Child Health Outcomes
We will assess the child's health outcomes by using a questionnaire administered to the caregiver. The questionnaire will ask a range of yes or no questions about child diarrhea, respiratory illness, fever, and child antibiotic use.
Percent weight loss
Percent weight loss will use body weight (kg) and pregnancy weight of the mother controlling for time of measurement. Percent weight loss will be calculated as ((current weight - pregnancy weight) / pregnancy weight) × 100.
Mother and Child Hemoglobin Levels
We will assess the mother and child anemia levels. The HemoCue Hb 301 will be used to give an instant measurement of the Haemoglobin (Hb) level of the patient. Capillary blood will be collected through a finger prick. Blood samples drawn for the haemoglobin assessment will be discarded after the test. Iron levels will be analyzed as a continuous outcome.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Swiss Tropical & Public Health Institute
Lead sponsor
Centre Suisse de Recherches Scientifique en Côte d'Ivoire
Collaborator
This trial is not recruiting at the moment. You can still explore other options: